Lantern Pharma Inc (NAS:LTRN)
$ 1.905 +0.035 (+1.87%) Market Cap: 24.35 Mil Enterprise Value: 17.03 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Q1 2025 Lantern Pharma Inc Earnings Call Transcript

May 15, 2025 / 01:00PM GMT
Release Date Price: $3.86 (-4.93%)
Operator

Good morning, and welcome to our first quarter 2025 earnings call. As a reminder, this call is being recorded. (Operator Instructions) A webcast replay of today's conference call will be available on our website at lanternpharma.com shortly after the call.

We issued a press release before the market opened today, summarizing our financial results and progress across the company for the first quarter ended March 31, 2025. A copy of this release is available through our website at lanternpharma.com, where you will also find a link to the slides management will be referencing on today's call.

We would like to remind everyone that remarks about future expectations, performance, estimates and prospects constitute forward-looking statements for purposes of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Lantern Pharma cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those anticipated. A number of factors could cause actual results to differ materially from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot